Clinical trial
Feasibility and Safety of Intravenous Sotalol Administered as a Loading Dose to Initiate Oral Sotalol Therapy in Adult Patients With Atrial Fibrillation (DASH-AF)
NCT04473807 is registered in ClinicalTrials.gov with Kansas City Heart Rhythm Research Foundation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Feasibility and Safety of Intravenous Sotalol Administered as a Loading Dose to Initiate Oral Sotalol Therapy in Adult Patients With Atrial Fibrillation (DASH-AF)
- Lead sponsor
- Kansas City Heart Rhythm Research Foundation
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- January 2, 2021
- Completion date
- June 30, 2022
- Enrollment
- 80 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.